Technical Analysis for VKTX - Viking Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 8.38 -3.01% -0.26
VKTX closed up 4.98 percent on Tuesday, May 21, 2019, on 48 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical VKTX trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -3.01%
Bollinger Band Squeeze Range Contraction -3.01%
20 DMA Resistance Bearish 1.82%
Bollinger Band Squeeze Range Contraction 1.82%
NR7 Range Contraction 1.82%
NR7-2 Range Contraction 1.82%
Down 3 Days in a Row Weakness 1.82%
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%

Older signals for VKTX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for metabolic and endocrine disorders. Its lead clinical program includes VK0612, an orally available drug candidate for the treatment of type 2 diabetes. The company is also developing VK5211, an orally available drug candidate, which has completed Phase I trial for the treatment of cancer cachexia, a disease characterized by an uncontrolled decline in muscle mass. In addition, it is developing VK0214, a novel liver-selective thyroid hormone receptor beta agonist for lipid disorders, such as dyslipidemia and nonalcoholic steatohepatitis, as well as other preclinical programs for metabolic diseases and anemia. Viking Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.
Medicine Health Biopharmaceutical Cancer Medical Specialties Disease Diabetes Treatment Of Cancer Medication Anemia Hepatitis Metabolic Diseases Dyslipidemia Geriatrics Rehabilitation Medicine Lipid Disorders Non Alcoholic Fatty Liver Disease Steatohepatitis Cachexia
Is VKTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.0
52 Week Low 4.86
Average Volume 3,288,993
200-Day Moving Average 10.4808
50-Day Moving Average 8.8008
20-Day Moving Average 8.359
10-Day Moving Average 8.434
Average True Range 0.4894
ADX 14.0
+DI 19.9221
-DI 15.4849
Chandelier Exit (Long, 3 ATRs ) 7.4618
Chandelier Exit (Short, 3 ATRs ) 9.1032
Upper Bollinger Band 8.8868
Lower Bollinger Band 7.8312
Percent B (%b) 0.77
BandWidth 12.628305
MACD Line -0.1139
MACD Signal Line -0.1487
MACD Histogram 0.0348
Fundamentals Value
Market Cap 239.3 Million
Num Shares 27.7 Million
EPS -0.83
Price-to-Earnings (P/E) Ratio -10.41
Price-to-Sales 0.00
Price-to-Book 10.84
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.18
Resistance 3 (R3) 9.12 8.88 9.09
Resistance 2 (R2) 8.88 8.74 8.91 9.06
Resistance 1 (R1) 8.76 8.66 8.82 8.82 9.03
Pivot Point 8.52 8.52 8.55 8.55 8.52
Support 1 (S1) 8.40 8.38 8.46 8.46 8.25
Support 2 (S2) 8.16 8.30 8.19 8.22
Support 3 (S3) 8.04 8.16 8.19
Support 4 (S4) 8.10